Skip to content

Comparison Of Kanji Yukta Patrapottali And Kanji Dhara Therapy For Pain Relief In Patients With Rheumatoid Arthritis

A Comparative Clinical Study Of Kanji Yukta Patrapottali And Kanji Dhara In The Pain Management Of Amavata W.S.R To Rheumatoid Arthritis - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102165
Enrollment
74
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

None listed

Sponsors

Dr Monali Prakash Keni
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients Showing Signs And Symptoms Mentioned In Classical Ayurveda Text (Sandhi Shool,Sandhi Shotha,Sandhi stabhdhata) 2.Patients Of Either Gender 3.Patient Diagnosed With Anti CCP Positive

Exclusion criteria

Exclusion criteria: 1.Other Inflammatory Disease eg-Lupus or Psoratic Arthritis 2.Significant Comorbidities eg-Severe Liver or Kidney Disease 3.Pregnancy or Lactating Women 4.Recent Infection 5.Certain Medication eg-Immunosupressant 6.Allergic And Sensitivities 7.Patient Having Disabilities Arthritis,Patient Having Permanent Deformity will Not Be Chosen 8.Choronicity of Disease More Than 10 Years 9.Patients Taking Regular Steriods ,Anti inflammatory Drugs And Methotrexate 10.Sweden Ayogya As Per Ayurveda Text

Design outcomes

Primary

MeasureTime frame
1.To Assess The Effect Of Kanji Yukta Patrapottali In Reducing Pain ,Swelling,Stiffness In AmavataTimepoint: Baseline, Day 7,Day 15

Secondary

MeasureTime frame
To Analyse The Effect Of Treatment Using Standard Tool Like DAS28 ScoreTimepoint: Baseline,Day 7

Countries

India

Contacts

Public ContactDr Kalpna Gholap Dhomse

Dr G D Pol Foundation YMT Ayurvedic Medical College And Hospital Kharghar

kalpu.gholap@gamil.com9833971482

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026